查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837188

辅助人工心臟市场（按流量等级、设备类型、适应症、产品类型和最终用户划分）—2025-2032 年全球预测

Ventricular Assist Device Market by Flow Class, Device Type, Indication, Product, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年辅助人工心臟市场将成长至 34.1 亿美元，复合年增长率为 6.48%。

主要市场统计数据
基准年2024年 20.6亿美元
预计2025年 21.9亿美元
预测年份：2032年 34.1亿美元
复合年增长率（%） 6.48%

从临床、技术和医疗系统角度看辅助人工心臟的现状

过去十年，辅助人工心臟为晚期心臟衰竭治疗途径中不可或缺的选择。现代辅助人工心臟的结构着重于降低血栓形成风险、结构紧密和能量效率，这些因素的结合使其在老年患者和併发症患者中的应用范围不断扩大。同时，先进的手术方法和经经皮联合策略降低了手术全期风险，使其在三级医疗机构和专科中心广泛应用。

此外，临床模式的转变正在模糊临时和长期机械循环支持之间的传统界限，促使临床医生考虑在某些患者群体的疾病发展早期采用器械治疗。付款人和医疗保健系统越来越注重基于价值的治疗结果和降低再入院率，这提升了器械的长期性能和全面的植入护理计划的重要性。因此，製造商、临床医生和医院正在共同努力，收集证据和真实世界数据，以量化改善生活品质和长期生存的益处。

同时，法律规范也不断发展，以促进器械的迭代改进，在保障病人安全的同时，兼顾病患的及时取得和强有力的上市后监管。这些动态共同构成了一个复杂而又肥沃的环境，为整个辅助人工心臟辅助治疗生态系统的创新、伙伴关係和策略差异化发展提供了机会。

确定将重塑机械循环支持临床实践、技术开发和商业模式的转型转变

一些趋同的变化正在发生，这些变化正在重新定义辅助人工心臟的开发、评估和部署方式。首先，包括轴向和离心平台在内的连续流设计方面的工程进步正在提高血流动力学效率和耐用性，从而影响手术选择和长期管理。其次，数位遥测和远端监控功能的整合使得主动管理设备性能和患者状态成为可能，从而缩短了门诊医生和植入团队之间的回馈迴路。

同时，临床证据正在将适应症从传统的「过渡到移植」模式扩展到「过渡到復原」模式以及针对特定族群的最终治疗，这促使多学科团队重新评估适应症标准。以患者为中心的治疗结果的兴起，正在将衡量标准从生存率转向功能状态和生活质量，从而影响报销讨论和临床应用。此外，随着企业追求垂直整合、製造扩充性和跨辖区监管协调，以加快迭代设备更新的上市时间，製造和供应链策略也不断发展。

最后，医疗设备製造商、学术中心和卫生系统之间的策略合作正在加速转化研究和真实世界证据的产生。此类伙伴关係有助于促进适应性临床试验设计和註册，从而更好地了解器械的长期性能和併发症，从而为患者选择、手术全期通讯协定和植入后护理的迭代改进提供资讯。

检验近期和预期的美国关税政策变化对辅助人工心臟价值炼和筹资策略的累积影响

2025年实施的关税调整增加了整个辅助人工心臟供应链的复杂性，影响零件、成品系统和辅助耗材。这些政策变化加强了医院采购团队和设备製造商的采购审查力度，促使他们重新检视筹资策略、供应商多元化和製造外包管理。为此，一些製造商已与合约製造商合作，以加快关键零件的本地生产，并降低贸易相关价格波动带来的风险。

医疗保健提供者已采取相应措施，加强采购管治，并寻求签订长期供应协议，以确保价格稳定和医疗服务的连续性。同时，规模较小的供应商和利基零件供应商正在寻求扩大规模，以消化关税相关的成本压力，从而可能促成整合。重要的是，临床团队正在密切监测设备供应和服务部件的间接影响，因为即使是轻微的中断也可能影响计画中的植入项目和植入后支援。

政策不确定性也增强了总成本分析在采购决策中的作用，医院系统寻求提高土地购买成本、保固条款和服务网路可靠性方面的透明度。因此，积极调整商业模式，提供配套服务协议、更优的前置作业时间保证和本地化支援的製造商，将在调整后的资费环境中保持竞争优势。

解释流程架构、设备类型、临床指征、产品组合和护理环境的细分动态，以发现策略机会和临床交叉点

连续流系统和脉动平台之间流动结构的区别持续影响临床实践。连续流装置，尤其是轴向和离心式装置，因其可靠性和小巧外形而备受青睐，而脉动技术则在临床上更倾向于生理性脉动的领域中占据着独特的地位。左心室辅助、右心室辅助和双心室辅助装置类型的分类清楚地展现了治疗意图如何决定技术设计。虽然左心室辅助是最常用的慢性支持方法，但右心室辅助和双心室辅助在急性缺血和复杂的手术全期病例中也发挥着重要作用。

基于适应症（例如復健过渡期、移植过渡期和最终照护）的差异化不仅影响临床决策，还会影响医疗保健系统内的方案设计。在产品层面，选择外部设备或植入式设备，也与患者的生活方式、感染风险管理以及长期设备维护策略相互关联。最后，终端使用者细分（包括门诊手术中心和医院）凸显了医疗服务模式的演变。

这些细分轴的交集产生了细微的采用模式和服务需求，这表明，如果製造商和供应商能够将其产品开发、临床支援和培训计划与这些差异化需求相结合，那么他们将能够更好地满足临床医生的偏好和患者的期望。

法律规范、付款人动态和临床应用的地区差异影响着全球的商业化和证据生成策略

美洲地区拥有先进的三级医疗网络、集中的植入专家队伍，以及强调强有力的临床证据和上市后监测的监管路径，这些条件有利于先进植入技术的采用和综合护理方案的落地。相较之下，欧洲、中东和非洲地区情况复杂，报销机制、国家卫生部门流程和医院采购模式差异巨大，因此需要灵活的商业化策略和针对特定区域的临床参与。同时，在亚太地区，一些市场正在快速发展医疗保健基础设施，而另一些市场则拥有高度发展的卓越中心，同时注重成本效益解决方案和尖端创新技术的采用。

在全部区域，当地的临床实践模式、外科医生的经验以及心臟衰竭专科计画的密度都会影响新设备架构融入治疗流程的速度。此外，各地区在协调监管和加强上市后资料收集方面的努力正在减少跨司法管辖区的证据生成障碍，但实施时间仍然不均衡。因此，寻求全球扩张的公司必须调整其临床教育、服务网络和报​​销策略，以满足不同的付款人期望和医疗保健服务模式，同时利用区域卓越中心来推动临床医生的采用并建立可靠的真实世界证据。

整个设备生态系统的竞争动态和伙伴关係策略，重点是平台创新、服务整合和证据主导的差异化

一些公司优先改进设备，以提高血液相容性或电池效率，而其他公司则强调整合远端监控和预测分析的平台计划。设备开发商与学术机构之间的策略伙伴关係加速了转化研究和临床检验，从而缩短了迭代改进週期。此外，垂直整合的服务网络和不断壮大的内部技术支援团队已成为寻求与医院建立长期合作关係并确保植入设备高正常运转率的公司的关键差异化因素。

併购仍然是取得互补技术、增强服务能力和扩大地域覆盖范围的重要途径，尤其对于那些寻求填补产品线空白或增强上市后监测基础设施的公司而言。同时，新参与企业和专业零件供应商正凭藉传动系统感染缓解、感测器整合和血液动力学优化演算法等领域的利基创新，挑战现有企业。这些竞争动态共同作用，不仅优先考虑设备性能，还优先考虑临床培训的品质、保固和服务承诺的清晰度，以及支持长期患者疗效的证据深度。

为了加强设备治疗的供应弹性、证据产生和价值主导的商业模式，製造商和医疗保健提供者应采取以下策略重点：

首先，我们将优先投资于上市后资料收集和远端监控基础设施，以验证设备在现实世界中的效能，并推动早期临床应用。将证据产生工作与付款人需求和临床医生的优先事项相结合，将有助于促进报销讨论，并支持更广泛的应用。其次，我们将透过多元化关键零件供应商，并尽可能探索本地製造伙伴关係，增强供应链韧性，以减少贸易相关中断和前置作业时间波动带来的风险。第三，我们将开发捆绑式产品，将设备硬体、保固范围和可预测的服务合约结合在一起，以简化采购流程并降低医院系统的营运风险。

此外，扩大临床医生教育项目，将模拟、监考和跨学科护理团队培训纳入其中，以最大程度地减少手术全期併发症并优化患者选择。利用区域卓越中心促进P2P知识转移，并产生高品质的真实世界证据。最后，采用以病人为中心的产品开发概念，强调生活品质、易用性和长期照护协作。透过协调一致地实施这些建议，领导者可以增强竞争优势，同时改善临床结果和营运可靠性。

透过整合主要临床访谈、次要证据综合和相关人员检验的严格混合方法研究途径获得可靠的见解

本研究整合了定性和定量方法，旨在提供关于临床实践、技术趋势和商业性动态的全面视角。主要资料收集包括对临床医生、临床工程师、采购主管和监管专家的结构化访谈，以了解现场对设备性能、服务期望和采用障碍的观点。二次文献整合则利用了同行评审的临床研究、指南声明、监管文件和技术白皮书，以将主要研究结果与临床声明联繫起来并检验。

此外，我们也透过结构化的相关人员检验会议来协调分歧、检验分析得出的假设并完善建议。必要时，我们会交叉引用器械技术规格、台架试验报告和上市后监测摘要，以支持关于器械构造和临床应用的主张。我们透过对资讯来源应用透明的纳入标准、记录访谈通讯协定以及采用迭代三角测量法来提高可靠性，从而保持了调查方法的严谨性。这种混合方法设计确保了见解以临床为基础，并与决策者的操作相关。

将技术进步、不断发展的临床实践和持续推进机械循环支援的策略要求结合起来的简明综合

综上所述，辅助人工心臟领域正处于曲折点，工程技术的进步、临床适应症的演变以及商业性现实的变迁，共同创造了新的机会和挑战。设备在流量技术、小型化和数位化整合方面的改进，正在扩大患者可及性和更精细的护理路径，而与关税相关的供应链压力以及监管和报销的地区差异，则要求企业製定适应性的商业和营运策略。因此，成功的组织将是那些将卓越的技术与强大的证据生成、弹性供应网络以及全面的临床医生和患者支持计划相结合的组织。

展望未来，製造商、临床负责人和医疗系统之间需要协调一致，优先收集真实世界数据，简化采购模式，并加强培训，这对于将技术潜力转化为持续的临床效益至关重要。透过让相关人员专注于这些综合优先事项，我们可以改善患者预后，降低系统层面的风险，并将器械治疗定位为晚期心臟衰竭治疗模式中持久的、以患者为中心的选择。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 配备无线经皮能量传输系统的完全植入式左心室辅助装置的采用率日益提高
  • 整合机器学习演算法对辅助人工心臟併发症进行预测监测和早期预警
  • 磁浮帮浦技术的发展可减少 VAD 患者的溶血和装置相关血栓症
  • 目的地治疗适应症的扩大正在推动对长期辅助人工心臟支持的需求
  • 临床试验评估生物相容性表面涂层以最大程度降低 VAD植入的免疫反应和感染风险
  • 微型儿科连续流泵的设计促进了辅助人工心臟计画的发展
  • 监管核准和报销政策塑造下一代植入式辅助设备的可及性
  • 新兴的远端患者监护平台，用于植入式心室辅助装置的即时数据传输

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章辅助人工心臟市场流程分类

  • 常规流量
    • 轴流
    • 离心流
  • 脉动流

第九章辅助人工心臟市场（依设备类型）

  • 两个房间
  • 左边
  • 正确的

第十章辅助人工心臟市场（依适应症）

  • 通往復苏的桥樑
  • 移植桥樑
  • 目的地疗法

第 11 章。辅助人工心臟市场（按产品）

  • 外部的
  • 嵌入式

第 12 章辅助人工心臟市场（依最终使用者）

  • 门诊手术中心
  • 医院

第十三章辅助人工心臟市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章辅助人工心臟市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。辅助人工心臟市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Medtronic plc
    • Abiomed, Inc.
    • LivaNova PLC
    • Berlin Heart GmbH
    • Jarvik Heart, Inc.
    • CARMAT SA
    • CorWave SAS
    • Terumo Corporation
    • SynCardia Systems, LLC
Product Code: MRR-034B5003038B

The Ventricular Assist Device Market is projected to grow by USD 3.41 billion at a CAGR of 6.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.06 billion
Estimated Year [2025] USD 2.19 billion
Forecast Year [2032] USD 3.41 billion
CAGR (%) 6.48%

Framing the contemporary ventricular assist device landscape with clinical, technological, and health-system context

Over the past decade, ventricular assist devices have transitioned from niche salvage therapies to integral options within advanced heart failure care pathways, driven by improvements in durability, biocompatibility, and implantation techniques. Contemporary device architectures emphasize reduced thrombogenicity, smaller form factors, and energy efficiency, which together have expanded candidacy among older and more comorbid patients. Simultaneously, refined surgical approaches and percutaneous-adjunct strategies have lowered perioperative risk, thereby enabling wider institutional adoption across tertiary and specialized centers.

Moreover, shifting clinical paradigms have blurred traditional boundaries between temporary and long-term mechanical circulatory support, prompting clinicians to consider device therapy earlier in the disease course for select patient cohorts. Payers and health systems are increasingly focused on value-based outcomes and readmission reduction, which elevates the importance of longitudinal device performance and comprehensive peri-implant care programs. As a result, manufacturers, clinicians, and hospitals are coalescing around evidence-generation and real-world data initiatives to quantify quality-of-life improvements and long-term survival benefits.

In parallel, regulatory frameworks continue to evolve to balance timely patient access with robust post-market surveillance, encouraging iterative device enhancements while maintaining patient safety. Taken together, these dynamics have created a complex but fertile environment for innovation, partnership, and strategic differentiation across the ecosystem supporting ventricular assist device therapy.

Identifying the transformative shifts reshaping clinical practice, technology development, and commercial models in mechanical circulatory support

Several convergent shifts are redefining how ventricular assist devices are developed, evaluated, and deployed. First, engineering advances in continuous flow designs, including axial and centrifugal platforms, have enhanced hemodynamic efficiency and durability, which in turn influence surgical selection and long-term management. Second, integration of digital telemetry and remote monitoring capabilities is enabling proactive management of device performance and patient status, thus shortening feedback loops between outpatient clinicians and implant teams.

Concurrently, clinical evidence is expanding indications beyond classic bridge-to-transplant scenarios toward bridge-to-recovery and destination therapy for select populations, prompting multidisciplinary teams to reassess candidacy criteria. The rise of patient-centered outcomes has shifted evaluation metrics to include functional status and quality of life, not solely survival, which affects reimbursement conversations and clinical adoption. Furthermore, manufacturing and supply chain strategies are evolving as companies pursue vertical integration, production scalability, and regulatory harmonization across jurisdictions to reduce time to market for iterative device updates.

Finally, strategic collaborations among device manufacturers, academic centers, and health systems are accelerating translational research and real-world evidence generation. These partnerships are fostering adaptive clinical trial designs and registries that better capture long-term device performance and complications, thereby informing iterative improvements in patient selection, perioperative protocols, and post-implant care.

Examining the cumulative implications of recent and anticipated United States tariff policy changes for the ventricular assist device value chain and procurement strategies

Tariff adjustments implemented in 2025 have introduced complexity across the ventricular assist device supply chain, affecting components, finished systems, and ancillary disposables. These policy changes have increased procurement scrutiny among hospital purchasing teams and device manufacturers, prompting reassessments of sourcing strategies, supplier diversification, and inventory management. In response, some manufacturers have accelerated localization of critical component production and engaged contract manufacturers to mitigate exposure to trade-related price volatility.

Healthcare providers have reacted by enhancing procurement governance and exploring longer-term supply agreements to provide price stability and continuity of care. At the same time, smaller suppliers and niche component vendors have experienced differential impacts, leading to potential consolidation as organizations seek scale to absorb tariff-related cost pressures. Importantly, clinical teams are monitoring any indirect effects on device availability and service parts, because even modest disruptions can influence scheduled implant programs and post-implant support.

Policy uncertainty has also elevated the role of total cost of care analyses in procurement decisions, with hospital systems demanding greater transparency around landed costs, warranty terms, and service network reliability. As a result, manufacturers that proactively adapt their commercial models to offer bundled service agreements, improved lead-time assurances, and localized support are positioned to maintain competitive advantage under the revised tariff environment.

Interpreting segmentation dynamics across flow architecture, device type, clinical indication, product configuration, and care setting to reveal strategic opportunities and clinical intersections

Flow architecture distinctions between continuous flow systems and pulsatile platforms continue to shape clinical practice, with continuous flow devices-particularly axial and centrifugal configurations-favored for their reliability and smaller profiles, whereas pulsatile technologies retain a defined niche where physiologic pulsatility is clinically prioritized. Device type segmentation into left, right, and biventricular systems underscores how therapeutic intent drives technological design; left ventricular support remains the most commonly deployed modality for chronic support, while right and biventricular solutions play critical roles in acute decompensation and complex perioperative cases.

Indication-based differentiation across bridge-to-recovery, bridge-to-transplant, and destination therapy informs not only clinical decision-making but also programmatic design within health systems, as each indication demands distinct pre-implant evaluation, follow-up care pathways, and psychosocial support models. Product-level choices between external and implantable systems further interact with patient lifestyle considerations, infection risk management, and long-term device maintenance strategies. Finally, end-user segmentation that includes ambulatory surgical centers alongside hospitals highlights evolving care-delivery models, with ambulatory settings increasingly managing select perioperative workflows while hospitals retain responsibility for complex implants and long-term management.

Together, these segmentation axes intersect to create nuanced adoption patterns and service needs, suggesting that manufacturers and providers who align product development, clinical support, and training programs to these differentiated requirements will be better positioned to address clinician preferences and patient expectations.

Regional distinctions in regulatory frameworks, payer dynamics, and clinical adoption that shape commercialization and evidence-generation strategies across global territories

The Americas region features advanced tertiary care networks, a high concentration of specialized implant centers, and regulatory pathways that emphasize robust clinical evidence and post-market surveillance; these conditions support the adoption of advanced implantable technologies and complex care programs. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where reimbursement mechanisms, national health authority processes, and hospital procurement models vary significantly, driving the need for flexible commercialization strategies and region-specific clinical engagement. Meanwhile, Asia-Pacific encompasses rapidly developing health infrastructure in certain markets alongside highly advanced centers of excellence in others, creating a dual focus on cost-effective solutions and cutting-edge innovation adoption.

Across these regions, local clinical practice patterns, surgeon experience, and the density of specialized heart failure programs influence how quickly new device architectures are integrated into treatment algorithms. Furthermore, regulatory harmonization efforts and regional initiatives to strengthen post-market data collection are beginning to reduce barriers to multi-jurisdictional evidence generation, although implementation timelines remain uneven. As a result, companies pursuing global expansion must tailor clinical education, service networks, and reimbursement strategies to accommodate diverse payer expectations and healthcare delivery models while leveraging regional centers of excellence to accelerate clinician adoption and build robust real-world evidence.

Competitive dynamics and partnership strategies that emphasize platform innovation, service integration, and evidence-led differentiation across the device ecosystem

Industry participants have pursued divergent strategies to differentiate offerings: some prioritize incremental device refinements to improve hemocompatibility and battery efficiency, while others emphasize platform initiatives that integrate remote monitoring and predictive analytics. Strategic partnerships between device developers and academic institutions have accelerated translational research and clinical validation, enabling faster cycles of iterative improvement. In addition, vertical integration of service networks and the expansion of in-house technical support teams have emerged as critical differentiators for companies seeking to secure long-term hospital relationships and ensure high uptime for implanted devices.

Mergers and acquisitions remain a pathway for acquiring complementary technologies, bolstering service capabilities, and expanding geographic reach, particularly where companies seek to plug gaps in product lines or augment post-market surveillance infrastructure. At the same time, newer entrants and specialized component suppliers are challenging incumbents by offering niche innovations in areas such as driveline infection mitigation, sensor integration, and hemodynamic optimization algorithms. Collectively, these competitive dynamics prioritize not only device performance but also the quality of clinical training, clarity of warranty and service commitments, and the depth of evidence supporting long-term patient outcomes.

Actionable strategic priorities for manufacturers and providers to reinforce supply resilience, evidence generation, and value-driven commercial models in device therapy

First, prioritize investment in post-market data collection and remote monitoring infrastructure to demonstrate real-world device performance and drive earlier clinical acceptance. Aligning evidence-generation efforts with payer requirements and clinician priorities will facilitate reimbursement discussions and support broader adoption. Second, strengthen supply chain resilience by diversifying suppliers of critical components and by exploring localized manufacturing partnerships where feasible to reduce exposure to trade-related disruption and lead-time variability. Third, develop bundled commercial offerings that combine device hardware, warranty coverage, and predictable service agreements to simplify procurement and reduce operational risk for hospital systems.

Moreover, expand clinician education programs that incorporate simulation, proctorship, and multidisciplinary care-team training to minimize perioperative complications and optimize patient selection. Leverage regional centers of excellence to accelerate peer-to-peer knowledge transfer and to generate high-quality real-world evidence. Finally, adopt a patient-centered product development mindset that emphasizes quality of life, ease of use, and long-term care coordination, because these factors increasingly drive device preference among clinicians and patients alike. By implementing these recommendations in concert, leaders can strengthen competitive positioning while improving clinical outcomes and operational reliability.

A rigorous mixed-methods research approach integrating primary clinical interviews, secondary evidence synthesis, and stakeholder validation for reliable insights

The research approach integrates qualitative and quantitative methods to produce a comprehensive view of clinical practice, technology trends, and commercial dynamics. Primary data collection involves structured interviews with clinicians, clinical engineers, procurement leaders, and regulatory specialists to capture frontline perspectives on device performance, service expectations, and adoption barriers. Secondary literature synthesis draws on peer-reviewed clinical studies, guideline statements, regulatory communications, and technical white papers to contextualize primary findings and to verify clinical assertions.

In addition, structured stakeholder validation sessions were used to reconcile divergent viewpoints, test hypotheses emerging from the analysis, and refine recommendations. Where appropriate, device technical specifications, bench-test reports, and post-market surveillance summaries were cross-referenced to corroborate claims about device architecture and clinical application. Throughout, methodological rigor was maintained by applying transparent inclusion criteria for sources, documenting interview protocols, and employing iterative triangulation to enhance reliability. This mixed-methods design ensures that the insights are both clinically grounded and operationally relevant for decision-makers.

A concise synthesis linking technological advancement, clinical practice evolution, and strategic imperatives for sustainable progress in mechanical circulatory support

In synthesis, the ventricular assist device field is at an inflection point where engineering advances, evolving clinical indications, and shifting commercial realities converge to create new opportunities and challenges. Device improvements in flow technology, miniaturization, and digital integration are enabling broader patient access and more refined care pathways, while tariff-related supply-chain pressures and regional variability in regulation and reimbursement require adaptive commercial and operational strategies. Consequently, successful organizations will be those that combine technical excellence with robust evidence-generation, resilient supply networks, and comprehensive clinician and patient support programs.

Looking ahead, coordinated efforts among manufacturers, clinical leaders, and health systems to prioritize real-world data collection, streamline procurement models, and enhance training will be essential to translate technological promise into sustained clinical benefit. By focusing on these integrated priorities, stakeholders can improve patient outcomes, reduce system-level risks, and position device therapy as a durable, patient-centered option within advanced heart failure care paradigms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of fully implantable left ventricular assist devices with wireless transcutaneous energy transmission systems
  • 5.2. Integration of machine learning algorithms for predictive monitoring and early warning of ventricular assist device complications
  • 5.3. Development of magnetically levitated pump technology to reduce hemolysis and device-related thrombosis in VAD patients
  • 5.4. Expansion of destination therapy indications driving demand for long-term durable ventricular assist device support
  • 5.5. Clinical trials assessing biocompatible surface coatings to minimize immune response and infection risks in VAD implants
  • 5.6. Growth of pediatric ventricular assist device programs fueled by miniaturized continuous flow pump designs for children
  • 5.7. Regulatory approvals and reimbursement policies shaping accessibility of next-generation implantable assist devices
  • 5.8. Emergence of remote patient monitoring platforms for real-time data transmission from implanted ventricular assist devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ventricular Assist Device Market, by Flow Class

  • 8.1. Continuous Flow
    • 8.1.1. Axial Flow
    • 8.1.2. Centrifugal Flow
  • 8.2. Pulsatile Flow

9. Ventricular Assist Device Market, by Device Type

  • 9.1. Biventricular
  • 9.2. Left
  • 9.3. Right

10. Ventricular Assist Device Market, by Indication

  • 10.1. Bridge To Recovery
  • 10.2. Bridge To Transplant
  • 10.3. Destination Therapy

11. Ventricular Assist Device Market, by Product

  • 11.1. External
  • 11.2. Implantable

12. Ventricular Assist Device Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Ventricular Assist Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ventricular Assist Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ventricular Assist Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Medtronic plc
    • 16.3.3. Abiomed, Inc.
    • 16.3.4. LivaNova PLC
    • 16.3.5. Berlin Heart GmbH
    • 16.3.6. Jarvik Heart, Inc.
    • 16.3.7. CARMAT SA
    • 16.3.8. CorWave SAS
    • 16.3.9. Terumo Corporation
    • 16.3.10. SynCardia Systems, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VENTRICULAR ASSIST DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VENTRICULAR ASSIST DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VENTRICULAR ASSIST DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 234. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 235. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 236. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 237. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 240. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 241. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 242. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 243. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 273. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 276. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 277. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 278. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 279. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 284. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 285. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 286. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 287. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 290. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 291. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 292. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 293. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 298. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 299. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 300. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 324. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2